Yan Liu

发表

RECIST 1.1-Update and clarification: From the RECIST committee.

Erich P Huang, L. Schwartz, J. Wolchok, 2016, European journal of cancer.

Imaging biomarker roadmap for cancer studies

Stuart A. Taylor, Erich P Huang, J. Wason, 2016, Nature Reviews Clinical Oncology.

EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems

W. Oyen, R. Boellaard, B. Krause, 2017, European Journal of Nuclear Medicine and Molecular Imaging.

Repeatability and reproducibility of ADC measurements: a prospective multicenter whole-body-MRI study

J. Vandemeulebroucke, L. Collette, N. Michoux, 2021, European Radiology.

Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group.

B. V. Van Beers, Yan Liu, K. Herrmann, 2018, European journal of cancer.

Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042).

L. Collette, Yan Liu, A. Pica, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Degeneration in the Zygapophysial Joint of the Fifth Lumbar Vertebra: The V-Shaped Sign Revealed by Bone Scintigraphy

Yan Liu, Q. Ruan, Xingmin Han, 2021, International journal of general medicine.

A risk management approach for imaging biomarker-driven clinical trials in oncology.

H. Kauczor, L. Shankar, Yan Liu, 2015, The Lancet. Oncology.

18 F-FDG PET / CT and ultrasonogrpahy in differentiated thyroid carcinoma patients with elevated serum levels of antithyroglobulin antibody , negative Tg and whole body 131 I scan

Yan Liu, Fangfang Chao, Yanxia Yu, 2018 .

Diagnostic report of high-resolution magnetic susceptibility weighted imaging for cerebral vascular amyloid angiopathy-related microbleeds

Yan Liu, Jiangwei Xie, Zhi-yan He, 2019 .

Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group.

L. Collette, L. Bidaut, O. Hoekstra, 2018, The Lancet. Oncology.

The role of response evaluation criteria in solid tumour in anticancer treatment evaluation: results of a survey in the oncology community.

D. Sargent, S. Litière, E. D. de Vries, 2014, European journal of cancer.

RECIST 1.1 - Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group.

Robert Ford, Otto S Hoekstra, Yan Liu, 2016, European journal of cancer.

Evaluation of diffusion-weighted MRI and (18F) fluorothymidine-PET biomarkers for early response assessment in patients with operable non-small cell lung cancer treated with neoadjuvant chemotherapy

Yan Liu, J. Waterton, N. deSouza, 2019, BJR open.

RECIST 1.1 for Response Evaluation Apply Not Only to Chemotherapy-Treated Patients But Also to Targeted Cancer Agents: A Pooled Database Analysis.

Erich P Huang, L. Schwartz, J. Dancey, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The future of clinical research in oncology: where are we heading to?

D. Lacombe, Yan Liu, 2013, Chinese clinical oncology.

Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial "concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma": Individual case review analysis.

Yan Liu, Damien C Weber, Enrico Clementel, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Preclinical Applications of 3'-Deoxy-3'-[18F]Fluorothymidine in Oncology - A Systematic Review

Yan Liu, J. Waterton, A. Shields, 2017, Theranostics.

The additional value of SPECT/CT fusion imaging in the diagnosis of ectopic gastric mucosa.

Yan Liu, Ruihua Wang, Shui Jin, 2020, JPMA. The Journal of the Pakistan Medical Association.

Imaging Biomarkers in Clinical Trials

Yan Liu, J. Waterton, 2017 .

Functional and molecular imaging in cancer drug development

Yan Liu, S. Collette, V. Bollineni, 2014 .

Validation of RECIST 1.1 for use with cytotoxic agents and targeted cancer agents (TCA): Results of a RECIST Working Group analysis of a 50 clinical trials pooled individual patient database.

Erich P Huang, L. Schwartz, J. Dancey, 2017 .

Diagnostic value of magnetic resonance versus computed tomography colonography for colorectal cancer

Yan Liu, Hong-fen Wu, Jihong Zhao, 2018, Medicine.

WITHDRAWN: The Changes of ADC Value, DCE-MRI Parameters and Their Influence on Neuropsychology in Prostate Cancer Patients after Endocrine Therapy Based on Magnetic Resonance Imaging

Yan Liu, Gen-ji Bai, Shang Ge, 2020, Neuroscience Letters.

Multidisciplinary quality assurance and control in oncological trials: Perspectives from European Organisation for Research and Treatment of Cancer (EORTC).

D. Lacombe, J. Machiels, Yan Liu, 2017, European journal of cancer.

Guidelines for quality control of PET/CT scans in a multicenter clinical study

Yan Liu, Ronald Boellaard, Sigrid Stroobants, 2017, EJNMMI Physics.

The changing world of drug development: an academic research organization's perspective on the "Seven Wonders" of the future world of anticancer drug development.

R. Stupp, D. Lacombe, Yan Liu, 2014, Chinese clinical oncology.

MRI Apparent Diffusion Coefficient (ADC) as a Biomarker of Tumour Response: Imaging-Pathology Correlation in Patients with Hepatic Metastases from Colorectal Cancer (EORTC 1423)

A. Jackson, J. Theysohn, S. Litière, 2023, Cancers.

Monitoring the response of bone metastases to treatment with Magnetic Resonance Imaging and nuclear medicine techniques: a review and position statement by the European Organisation for Research and Treatment of Cancer imaging group.

Yan Liu, F. Lecouvet, J. Talbot, 2014, European journal of cancer.

Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives

A. Jackson, T. Chenevert, D. Collins, 2017, European Radiology.

Repeatability and reproducibility of relative cerebral blood volume measurement of recurrent glioma in a multicentre trial setting.

S. Heiland, M. J. van den Bent, Yan Liu, 2019, European journal of cancer.